Retention of the nipple–areola complex with nipple-sparing mastectomy (NSM) techniques provides a more natural cosmetic result than procedures that sacrifice the nipple. While the oncologic safety of NSM is established by several studies, there is little long-term data on outcomes in BRCA mutation carriers with breast cancer.
Patients and Methods
BRCA1/2 mutation carriers who underwent NSM and immediate reconstruction from 2008 to 2019 were reviewed and patients with breast cancer on biopsy or final pathology were included. Patient demographics and tumor characteristics, as well as treatment, recurrence, and survival data were collected.
A total of 114 therapeutic NSM were performed in 105 BRCA mutation carriers (56 BRCA1, 47 BRCA2, and two women with both mutations). Median age was 45 years. Cancers were 18% stage 0, 52% stage I, 27% stage II, and 3% stage III. Mean invasive tumor size was 1.6 cm and 33 (35%) invasive tumors were triple negative. There were five (4.4%) positive nipple margins on final pathology; all underwent nipple excision. Most patients (80, 76%) received systemic therapy: 65 (62%) received chemotherapy and 48 (46%) received endocrine therapy. At 70 months median follow-up (range 15–150 months), no patient had developed a recurrence in the retained nipple–areola complex or at the site of a nipple excised for a positive margin. The rate of locoregional recurrence outside the nipple was 2.6%, and the rate of distant recurrence was 3.8%. Overall survival was 96%.
NSM is a safe option for BRCA1 and BRCA2 mutation carriers who undergo mastectomy for breast cancer.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Smith BL, Tang R, Rai U, et al. Oncologic safety of nipple-sparing mastectomy in women with breast cancer. J Am Coll Surg. 2017;225(3):361–5. https://doi.org/10.1016/j.jamcollsurg.2017.06.013.
Margenthaler JA, Gan C, Yan Y, et al. Oncologic safety and outcomes in patients undergoing nipple-sparing mastectomy. J Am Coll Surg. 2020;230(4):535–41. https://doi.org/10.1016/j.jamcollsurg.2019.12.028.
Woodward S, Willis A, Lazar M, Berger AC, Tsangaris T. Nipple-sparing mastectomy: a review of outcomes at a single institution. Breast J. 2020;26(11):2183–7. https://doi.org/10.1111/tbj.14088.
Frey JD, Alperovich M, Kim JC, et al. Oncologic outcomes after nipple-sparing mastectomy: a single-institution experience. J Surg Oncol. 2016;113(1):8–11. https://doi.org/10.1002/jso.24097.
Moo TA, Pinchinat T, Mays S, et al. Oncologic outcomes after nipple-sparing mastectomy. Ann Surg Oncol. 2016;23(10):3221–5. https://doi.org/10.1245/s10434-016-5366-1.
Ng YY, Tan VK, Pek WS, et al. Surgical and oncological safety of nipple-sparing mastectomy in an Asian population. Breast Cancer. 2019;26(2):165–71. https://doi.org/10.1007/s12282-018-0908-y.
Petit JY, Veronesi U, Orecchia R, et al. Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasia. Ann Oncol. 2012;23(8):2053–8. https://doi.org/10.1093/annonc/mdr566.
Galimberti V, Morigi C, Bagnardi V, et al. Oncological outcomes of nipple-sparing mastectomy: a single-center experience of 1989 patients. Ann Surg Oncol. 2018;25(13):3849–57. https://doi.org/10.1245/s10434-018-6759-0.
Wu ZY, Kim HJ, Lee JW, et al. Breast cancer recurrence in the nipple-areola complex after nipple-sparing mastectomy with immediate breast reconstruction for invasive breast cancer. JAMA Surg. 2019;154(11):1030–7.
Agha RA, Al Omran Y, Wellstead G, et al. Systematic review of therapeutic nipple-sparing versus skin-sparing mastectomy. BJS Open. 2018;3(2):135–45. https://doi.org/10.1002/bjs5.50119.
Poruk KE, Ying J, Chidester JR, et al. Breast cancer recurrence after nipple-sparing mastectomy: one institution’s experience. Am J Surg. 2015;209(1):212–7. https://doi.org/10.1016/j.amjsurg.2014.04.001.
Kurian AW, Canchola AJ, Gomez SL, Clarke CA. Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988–2013. Breast Cancer Res Treat. 2016;160(2):333–8. https://doi.org/10.1007/s10549-016-3992-8.
Wu ZY, Han HH, Kim HJ, et al. A propensity score-matched analysis of long-term oncologic outcomes after nipple-sparing versus conventional mastectomy for locally advanced breast cancer Ann Surg. 2020. https://doi.org/10.1097/SLA.0000000000004416.
Bailey CR, Ogbuagu O, Baltodano PA, et al. Quality-of-life outcomes improve with nipple-sparing mastectomy and breast reconstruction. Plast Reconstr Surg. 2017;140(2):219–26. https://doi.org/10.1097/PRS.0000000000003505.
Wei CH, Scott AM, Price AN, et al. Psychosocial and sexual well-being following nipple-sparing mastectomy and reconstruction. Breast J. 2016;22(1):10–7. https://doi.org/10.1111/tbj.12542.
Didier F, Radice D, Gandini S, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? Breast Cancer Res Treat. 2009;118(3):623–33. https://doi.org/10.1007/s10549-008-0238-4.
Didier F, Arnaboldi P, Gandini S, et al. Why do women accept to undergo a nipple sparing mastectomy or to reconstruct the nipple areola complex when nipple sparing mastectomy is not possible? Breast Cancer Res Treat. 2012;132(3):1177–84. https://doi.org/10.1007/s10549-012-1983-y.
Agarwal S, Agarwal S, Neumayer L, Agarwal JP. Therapeutic nipple-sparing mastectomy: trends based on a national cancer database. Am J Surg. 2014;208(1):93–8. https://doi.org/10.1016/j.amjsurg.2013.09.030.
Krajewski AC, Boughey JC, Degnim AC, et al. Expanded indications and improved outcomes for nipple-sparing mastectomy over time. Ann Surg Oncol. 2015;22(10):3317–23. https://doi.org/10.1245/s10434-015-4737-3.
Wong SM, Chun YS, Sagara Y, Golshan M, Erdmann-Sager J. National patterns of breast reconstruction and nipple-sparing mastectomy for breast cancer, 2005–2015. Ann Surg Oncol. 2019;26(10):3194–203. https://doi.org/10.1245/s10434-019-07554-x.
Barbieri E, Frusone F, Bottini A, et al. Evolution and time trends of nipple-sparing mastectomy: a single-center experience. Updates Surg. 2020;72(3):893–9. https://doi.org/10.1007/s13304-020-00796-5.
Valero MG, Muhsen S, Moo TA, et al. Increase in utilization of nipple-sparing mastectomy for breast cancer: indications, complications, and oncologic outcomes. Ann Surg Oncol. 2020;27(2):344–51. https://doi.org/10.1245/s10434-019-07948-x.
Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402–16. https://doi.org/10.1001/jama.2017.7112.
Jakub JW, Peled AW, Gray RJ, et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA Surg. 2018;153(2):123–9. https://doi.org/10.1001/jamasurg.2017.3422.
Stanek K, Zimovjanova M, Suk P, et al. Bilateral prophylactic nipple-sparing mastectomy: analysis of the risk-reducing effect in BRCA1/2 mutation carriers. Aesthetic Plast Surg. 2021. https://doi.org/10.1007/s00266-021-02506-x.10.1007/s00266-021-02506-x.
Garstka M, Henriquez A, Kelly BN, et al. How protective are nipple-sparing prophylactic mastectomies in BRCA1 and BRCA2 mutation carriers? Ann Surg Oncol. 2021;28(10):5657–62. https://doi.org/10.1245/s10434-021-10445-9.
Rocco N, Montagna G, Criscitiello C, et al. Nipple sparing mastectomy as a risk-reducing procedure for BRCA-mutated patients. Genes. 2021;12(2):253. https://doi.org/10.3390/genes12020253.
Yao K, Liederbach E, Tang R, et al. Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature [published correction appears in Ann Surg Oncol. 2014 Dec;21 Suppl 4:S788. Weissman, Scott (added)]. Ann Surg Oncol. 2015;22(2):370–376.
Peled AW, Irwin CS, Hwang ES, Ewing CA, Alvarado M, Esserman LJ. Total skin-sparing mastectomy in BRCA mutation carriers. Ann Surg Oncol. 2014;21(1):37–41. https://doi.org/10.1245/s10434-013-3230-0.
Manning AT, Wood C, Eaton A, et al. Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance. Br J Surg. 2015;102(11):1354–9. https://doi.org/10.1002/bjs.9884.
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106. https://doi.org/10.1016/S0140-6736(05)67887-7.
Coopey SB, Tang R, Lei L, et al. Increasing eligibility for nipple-sparing mastectomy. Ann Surg Oncol. 2013;20(10):3218–22. https://doi.org/10.1245/s10434-013-3152-x.
Rusby JE, Kirstein LJ, Brachtel EF, Michaelson JS, Koerner FC, Smith BL. Nipple-sparing mastectomy: lessons from ex vivo procedures. Breast J. 2008;14(5):464–70. https://doi.org/10.1111/j.1524-4741.2008.00623.x.
Colwell AS, Gadd M, Smith BL, Austen WG Jr. An inferolateral approach to nipple-sparing mastectomy: optimizing mastectomy and reconstruction. Ann Plast Surg. 2010;65(2):140–3. https://doi.org/10.1097/SAP.0b013e3181c1fe77.
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual (7th ed). New York, NY: Springer; 2010.
Amara D, Peled AW, Wang F, Ewing CA, Alvarado M, Esserman LJ. Tumor Involvement of the nipple in total skin-sparing mastectomy: strategies for management. Ann Surg Oncol. 2015;22(12):3803–8. https://doi.org/10.1245/s10434-015-4646-5.
Tang R, Coopey SB, Merrill AL, et al. Positive nipple margins in nipple-sparing mastectomies: rates, management, and oncologic safety. J Am Coll Surg. 2016;222(6):1149–55. https://doi.org/10.1016/j.jamcollsurg.2016.02.016.
Haslinger ML, Sosin M, Bartholomew AJ, et al. Positive nipple margin after nipple-sparing mastectomy: an alternative and oncologically safe approach to preserving the nipple-areolar complex. Ann Surg Oncol. 2018;25(8):2303–7. https://doi.org/10.1245/s10434-018-6569-4.
Miller CL, Specht MC, Skolny MN, et al. Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery. Breast Cancer Res Treat. 2012;135(3):781–9. https://doi.org/10.1007/s10549-012-2231-1.
Yang CQ, Ji F, Gao HF, et al. The role of sharp dissection in nipple-sparing mastectomy: a safe procedure with no necrosis of the nipple-areolar complex. Cancer Manag Res. 2019;11:10223–8. https://doi.org/10.2147/CMAR.S230787.
Reish RG, Lin A, Phillips NA, et al. Breast reconstruction outcomes after nipple-sparing mastectomy and radiation therapy. Plast Reconstr Surg. 2015;135(4):959–66. https://doi.org/10.1097/PRS.0000000000001129.
Colwell AS, Tessler O, Lin AM, et al. Breast reconstruction following nipple-sparing mastectomy: predictors of complications, reconstruction outcomes, and 5-year trends. Plast Reconstr Surg. 2014;133(3):496–506. https://doi.org/10.1097/01.prs.0000438056.67375.75.
Chirappapha P, Petit JY, Rietjens M, et al. Nipple sparing mastectomy: does breast morphological factor related to necrotic complications? Plast Reconstr Surg Glob Open. 2014;2(1):e99. https://doi.org/10.1097/GOX.0000000000000038.
Gould DJ, Hunt KK, Liu J, et al. Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy. Plast Reconstr Surg. 2013;132(3):330e–8e. https://doi.org/10.1097/PRS.0b013e31829ace49.
Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429–34. https://doi.org/10.1158/1078-0432.CCR-06-3045.
Ovcaricek T, Frkovic SG, Matos E, Mozina B, Borstnar S. Triple negative breast cancer - prognostic factors and survival. Radiol Oncol. 2011;45(1):46–52. https://doi.org/10.2478/v10019-010-0054-4.
Pogoda K, Niwińska A, Murawska M, Pieńkowski T. Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients. Med Oncol. 2013;30(1):388. https://doi.org/10.1007/s12032-012-0388-4.
We gratefully acknowledge the support of the Susan and Michael Schechter Research Fund and the Massachusetts General Hospital Breast Surgery Endowed Fellowship Fund for this study.
The authors have nothing to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Webster, A.J., Shanno, J.N., Santa Cruz, H.S. et al. Oncologic Safety of Nipple-Sparing Mastectomy for Breast Cancer in BRCA Gene Mutation Carriers: Outcomes at 70 Months Median Follow-Up. Ann Surg Oncol (2023). https://doi.org/10.1245/s10434-022-13006-w